Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


3D Molecular Sciences Presents its New Patented 3D Encoded Particle Array Tool for Multiplexing Bioassays at BioArray Europe


3D Molecular Sciences presented a poster providing new assay data on the Company’s multiplexing enabling platform technology for molecular medicine at the BioArray Europe conference, taking place in Cambridge, UK, on 1 October 2002. The new patented assay system consists of microfabricated encoded particles of a variety of designs, attachment chemistries and a choice of readers to interpret the results.

The poster presentation, entitled Several Assay Systems Presented Using a New Patented 3D Encoded Particle Array Tool for Multiplexing Bioassays, shows new data demonstrating the compatibility of the Company’s individually coded particles with a diverse range of assays including nucleic acids and cytokines. The Company’s technology platform offers an inexpensive and flexible tool to the pharmaceutical, biotech and clinical diagnostic industries that allows for a superior volume of tests, a scaleable capability and multiplexing of samples. It has the potential to screen for gene-linked diseases such as cancer, Alzheimer`s, obesity and cystic fibrosis. It can also offer great possibilities in compound library screening, environmental monitoring and in anti-terrorism systems.

Dr Elizabeth Hill, 3D Molecular Sciences’ CEO, said, “Our 3DMS™ 3D particle array tools are designed to carry out large-scale bioassay analysis required in drug discovery, drug development and in diagnostics in a low cost and fast manner. Our data presented at this conference clearly illustrates the capability this platform has, and we will continue to maintain our technology programme so we can exploit this platform to the full.”

The Company’s 3DMS™ particle array system is a new, patented assay and detection technology that uses individually microscopic encoded particles for the detection of biological content or biochemical interactions in a wide variety of analytical bioassays and test formats. Such formats are for proteomics, immunoassays gene expression and SNP analysis.

Work is currently underway on a number of further commercial assay systems to illustrate the 3DMS 3D-particle array capability. The Company has a strong patent position and welcomes the opportunity to discuss licensing and collaboration with commercial partners to build and develop this platform further with suitable commercial assay applications.

Caroline Stupnicka | alfa
Further information:

More articles from Health and Medicine:

nachricht Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
24.10.2016 | Universität Basel

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Oasis of life in the ice-covered central Arctic

24.10.2016 | Earth Sciences

‘Farming’ bacteria to boost growth in the oceans

24.10.2016 | Life Sciences

Light-driven atomic rotations excite magnetic waves

24.10.2016 | Physics and Astronomy

More VideoLinks >>>